terephthalamidine has been researched along with Nausea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, L; Clark, GM; De La Cruz, P; Eckardt, JR; Fields, SM; Hilsenbeck, SG; Kuhn, JG; New, P; Rodriguez, GI; Von Hoff, DD; Weiss, G | 1 |
1 trial(s) available for terephthalamidine and Nausea
Article | Year |
---|---|
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Body Weight; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Phthalimides; Treatment Outcome; Weight Loss | 1998 |